Rituximab in refractory sarcoidosis: a single centre experience

Sarcoidosis is a granulomatous disease whose outcome varies from spontaneous remission to chronic refractory disease. Provided that steroids represent the gold standard as a first line treatment, many immune suppressants drugs are currently used in the disease management. However, refractory disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Cinetto, Francesco, Compagno, Nicolò, Scarpa, Riccardo, Malipiero, Giacomo, Agostini, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556310/
https://www.ncbi.nlm.nih.gov/pubmed/26330764
http://dx.doi.org/10.1186/s12948-015-0025-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556310/
https://www.ncbi.nlm.nih.gov/pubmed/26330764
http://dx.doi.org/10.1186/s12948-015-0025-9

Ejemplares similares